Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totaling 40,960 shares, a decrease of 65.5% from the December 15th total of 118,829 shares. Approximately 2.8% of the company’s shares are sold short. Based on an average daily trading volume, of 34,610 shares, the short-interest ratio is currently 1.2 days. Based on an average daily trading volume, of 34,610 shares, the short-interest ratio is currently 1.2 days. Approximately 2.8% of the company’s shares are sold short.
Astrotech Stock Up 5.5%
Astrotech stock opened at $3.48 on Tuesday. The firm has a fifty day moving average of $3.50 and a 200-day moving average of $4.51. Astrotech has a 52-week low of $2.46 and a 52-week high of $8.01. The firm has a market capitalization of $6.12 million, a P/E ratio of -0.41 and a beta of 0.34.
Astrotech (NASDAQ:ASTC – Get Free Report) last announced its quarterly earnings results on Thursday, November 13th. The aerospace company reported ($2.07) earnings per share for the quarter. Astrotech had a negative return on equity of 59.71% and a negative net margin of 1,069.89%.The business had revenue of $0.30 million for the quarter.
Hedge Funds Weigh In On Astrotech
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Astrotech in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Astrotech currently has an average rating of “Sell”.
View Our Latest Analysis on ASTC
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Recommended Stories
- Five stocks we like better than Astrotech
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
